[DISCLOSURE] Kyongbo Pharm (214390) said on Sept. 21 that it has obtained a patent on manufacturing process of its hyperlipidemia treatment, based on rosuvastatin calcium.
Kyongbo Pharm earns patent for hyperlipidemia treatment manufacturing process
Published : Sept. 21, 2016 - 15:44:25
![[Exclusive] Ateez to return in November](https://wimg.heraldcorp.com/news/cms/2026/09/02/news-p.v1.20260902.76162fb0ba55493aad1c076f240d0750_R.jpg?type=h&h=120)